7 June 2019 - Deborah Wilkes
Archived
The US Food and Drug Administration (FDA) needs to "step up very quickly" with regulation for cannabidiol (CBD) products, says Scott Melville, president and chief executive officer of the US Consumer Healthcare Products Association (CHPA). According to Melville, the current situation in the US is like the "wild west".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.